What is the global market size of Sepsis Diagnostics Market?

Global Sepsis Diagnostics Market size was valued at USD 0.59 billion in 2021 and is poised to grow from USD 0.67 billion in 2022 to USD 1.30 billion by 2030, growing at a CAGR of 9.8% during the forecast period (2023-2030).

Who are the key vendors in the Global Sepsis Diagnostics Market?

The global sepsis diagnostic market is highly competitive, with several established players competing for market share. These companies are investing heavily in R&D activities to develop technologically advanced diagnostic solutions and gain a competitive edge. Moreover, strategic partnerships and collaborations with other companies and healthcare facilities are commonly observed in the market. Additionally, companies are focusing on expanding their geographic presence through acquisitions, partnerships, and collaborations. Furthermore, product launches, regulatory approvals, and patent filings are among the key strategies adopted by companies to strengthen their market position. 'Abbott Laboratories (US)', 'Becton, Dickinson and Company (US)', 'bioMérieux SA (France)', 'Cepheid (US)', 'F. Hoffmann-La Roche AG (Switzerland)', 'Hologic Inc. (US)', 'Imbio LLC (US)', 'Luminex Corporation (US)', 'MedMira Inc. (Canada)', 'Meridian Bioscience, Inc. (US)', 'Nanosphere (US)', 'QIAGEN N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'T2 Biosystems, Inc. (US)', 'Biomarck Pharmaceuticals Ltd. (UK)', 'Magnitude Biosciences (US)', 'Axis-Shield Diagnostics Ltd. (UK)', 'Biocartis Group NV (Belgium)', 'Inflammatix Inc. (US)', 'OpGen, Inc. (US)'

What is the key driver of Global Sepsis Diagnostics Market?

Rising incidence of hospital-acquired infections: The increasing occurrence of hospital-acquired infections (HAIs), commonly referred to as nosocomial infections, represents a significant global health concern. Among the most prevalent HAIs are urinary tract infections, pneumonia, and sepsis. These infections can have particularly severe consequences in vulnerable patient populations, including those who are immunocompromised, elderly, or suffering from chronic illnesses. In the United States, there is a troubling trend of rising sepsis incidence among hospitalized patients, with an annual increase of 8.7%. It is estimated that the United States witnesses over 1,000,000 cases of sepsis among hospitalized patients each year, as reported by the Centers for Disease Control and Prevention (CDC) in 2018. Given the rapid escalation of HAIs on a global scale, there is a heightened demand anticipated for sepsis diagnostic products in the years ahead.

What is the key market trend for Global Sepsis Diagnostics Market?

One of the key market trends in the global sepsis diagnostic market is the increasing adoption of point-of-care (POC) testing. POC tests are designed to provide rapid and accurate diagnosis of sepsis, which can significantly improve patient outcomes. POC tests are portable, easy-to-use, and can be conducted outside the traditional laboratory setting, making them ideal for use in emergency rooms, ambulances, and critical care units. The demand for POC tests is expected to increase over the forecast period, driven by the need for rapid diagnosis and the growing adoption of digital health technologies.

Which region accounted for the largest share in Sepsis Diagnostics Market?

North America dominated the sepsis diagnostic market due to the increasing incidence of sepsis and hospital-acquired infections, coupled with the presence of leading market players and advanced healthcare infrastructure. The US and Canada are the major contributors to the growth of the market in this region. In addition, the increasing awareness about sepsis and the availability of advanced diagnostic solutions are also driving the growth of the market in North America.

Sepsis Diagnostics Companies

Sepsis Diagnostics Market Competitive Landscape

Top Player’s Company Profiles in Global Sepsis Diagnostics Market

Abbott Laboratories (US)

Becton, Dickinson and Company (US)

bioMérieux SA (France)

Cepheid (US)

F. Hoffmann-La Roche AG (Switzerland)

Hologic Inc. (US)

Imbio LLC (US)

Luminex Corporation (US)

MedMira Inc. (Canada)

Meridian Bioscience, Inc. (US)

Nanosphere (US)

QIAGEN N.V. (Netherlands)

Thermo Fisher Scientific Inc. (US)

T2 Biosystems, Inc. (US)

Biomarck Pharmaceuticals Ltd. (UK)

Magnitude Biosciences (US)

Axis-Shield Diagnostics Ltd. (UK)

Biocartis Group NV (Belgium)

Inflammatix Inc. (US)

OpGen, Inc. (US)

Global Sepsis Diagnostics Market

FAQs

Sepsis Diagnostics Market size was valued at USD 0.63 Billion in 2023 and is poised to grow from USD 0.68 Billion in 2024 to USD 1.4 Billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The competitive landscape of the global sepsis diagnostics market is a highly competitive market impacted by the leading trends and the mix of prominent players and progressing vendors. The top-ranking companies, Abbott Laboratories, Roche, BioMérieux, Becton Dickinson, and Siemens Healthineers that are dominating the market with their broad distribution network and innovative offerings. Startups and the new entrants are modernizing new technologies like rapid testing solutions and AI-based diagnostics that improve competition and help the emerging enterprises to progress further. Improvements and expanding geographic presence are also supported by growing number of alliances between diagnostic companies, research institutes, and healthcare providers. 'Abbott Laboratories (US)', 'Becton, Dickinson and Company (US)', 'bioMérieux SA (France)', 'Cepheid (US)', 'F. Hoffmann-La Roche AG (Switzerland)', 'Hologic Inc. (US)', 'Imbio LLC (US)', 'Luminex Corporation (US)', 'MedMira Inc. (Canada)', 'Meridian Bioscience, Inc. (US)', 'Nanosphere (US)', 'QIAGEN N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'T2 Biosystems, Inc. (US)', 'Biomarck Pharmaceuticals Ltd. (UK)', 'Magnitude Biosciences (US)', 'Axis-Shield Diagnostics Ltd. (UK)', 'Biocartis Group NV (Belgium)', 'Inflammatix Inc. (US)', 'OpGen, Inc. (US)'

Increasing awareness and training programs for medical professionals regarding the significance of early detection of sepsis and its management is increasing. This is notably contributing to the steady adoption of diagnostic tests and associated services. Moreover, growing number of initiatives for educating the public for the symptoms and signs of sepsis promote timely medical guidance, thus resulting in diagnosis and testing.

Improvements in Molecular Diagnostics: In recent years, the use of next-generation sequencing (NGS) and polymerase chain reaction (PCR) has increased significantly with huge prominence. These techniques enable accurate and speedy detection of pathogens that help in majorly reducing the time needed for diagnosis in comparison with former culture methods. This is vital for early mediation in sepsis management.

Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the advanced healthcare infrastructure, increased cases of sepsis, and robust research and development investment. North America has a developed healthcare system with superior technology and a broad range of resources for diagnosis and associated services. Moreover, growing cases of sepsis and associated health conditions are notably impacting the demand for reliable and accurate diagnostic solutions. Also, the region is home to the leading pharmaceutical and biotech companies that are heavily investing in R&D, resulting in modernized diagnostic technologies. The key players profiled in the region include Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Hologic Inc., Luminex Corporation, Meridian Bioscience, Inc., and more.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Sepsis Diagnostics Market Competitive Landscape

Sepsis Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Sepsis Diagnostics Market Competitive Landscape

Sepsis Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Sepsis Diagnostics Market?

Who are the key vendors in the Sepsis Diagnostics Market?

What is the key driver of Sepsis Diagnostics Market?

What is the key market trend for Sepsis Diagnostics Market?

Which region accounted for the largest share in Sepsis Diagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300